Nephros, Inc. (NEPH) stock declined over -0.89%, trading at $1.86 on NASDAQ, down from the previous close of $1.88. The stock opened at $1.85, fluctuating between $1.84 and $1.87 in the recent session.
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Employees | 31 |
Beta | 1.186 |
Sales or Revenue | $14.24M |
5Y Sales Change% | 0.65% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Instruments & Supplies |
Nephros, Inc. (NASDAQ: NEPH) stock price is $1.86 in the last trading session. During the trading session, NEPH stock reached the peak price of $1.87 while $1.84 was the lowest point it dropped to. The percentage change in NEPH stock occurred in the recent session was -0.89% while the dollar amount for the price change in NEPH stock was -$0.02.
The NASDAQ listed NEPH is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Nephros, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Andrew Astor
Interim Chief Financial Officer & Advisor
Mr. Robert Banks
Pres, Chief Executive Officer & Director
Mr. Daron G. Evans
Chief Executive Officer of Specialty Renal Products, Inc
Mr. Greg Lucas
Pres of Aether Water Systems
Ms. Joleen C. Turner
Vice President of Marketing & Bus. Devel.
Vashone R. Thomas
Vice President of Quality, Regulatory, & HR
Brianne McGuire
Director of Brand & Marketing
Ms. Judy Mazzini
Controller
NEPH's closing price is 33.09% higher than its 52-week low of $1.40 where as its distance from 52-week high of $4.04 is -53.88%.
Number of NEPH employees currently stands at 31.
Official Website of NEPH is: https://www.nephros.com
NEPH could be contacted at phone 201 343 5202 and can also be accessed through its website. NEPH operates from 380 Lackawanna Place, South Orange, NJ 07079, United States.
NEPH stock volume for the day was 3.74K shares. The average number of NEPH shares traded daily for last 3 months was 11.73K.
The market value of NEPH currently stands at $19.65M with its latest stock price at $1.86 and 10.54M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com